CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 274 enrolled
Drug / intervention
RayOne EMV Toric IOL +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05985304
NCT05985304N/ACompleted
CompareCT.gov

Clinical Trial to Investigate the Safety and Effectiveness of a Hydrophilic EMV Toric Lens RAO210T in the Correction of Aphakia and Post-operative Corneal Astigmatism

Rayner Intraocular Lenses Limited·interventional·Posted Aug 14, 2023·Updated Jan 21, 2026

In Brief

A clinical study evaluating RayOne EMV Toric IOL, RayOne Monofocal IOL, and 1 other intervention for Cataract and Corneal Astigmatism. Completed, enrolled 274 participants across 9 sites.

Detailed Summary

The objectives of the clinical investigation are to determine the safety and performance of the RayOne EMV Toric (Model RAO210T) following unilateral implantation and approximately 6 months (120 to 180 days) of post-operative assessment, as a randomized comparison to aspheric monofocal control for low cylinder (1.50 D). This patient population with cataracts and low corneal cylinder (+1.00 to +1.50 D) will have the natural crystalline lens removed and replaced with an intraocular lens in the capsular bag.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract, Corneal Astigmatism
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedAug 14, 2023
Enrollment StartAug 10, 2023
Primary CompletionOct 23, 2024
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 2.9 years ago

Interventions

RayOne EMV Toric IOLdevice

Implantation of intraocular lens.

RayOne Monofocal IOLdevice

Implantation of intraocular lens.

Cataract Surgeryprocedure

Removal of natural crystalline lens due to cataracts